Pfizer Pays $14.5M To End Whistleblowers’ FCA Suit

Law360, New York (October 20, 2011, 7:08 PM EDT) -- Pfizer Inc. agreed to pay $14.5 million to resolve claims brought by two ex-employee whistleblowers that it used kickbacks and deceptive marketing to convince Medicaid providers to prescribe a bladder control drug for off-label purposes, plaintiffs' attorneys said Thursday.

Former Pfizer sales representatives David Wetherhold and Marci Drimer brought the False Claims Act suit in Massachusetts federal court on behalf of the U.S. government, 49 states and the District of Columbia in 2006. They alleged Pfizer promoted Detrol as a treatment for prostate enlargement, a condition...
To view the full article, register now.

Related

Sections

Case Information

Case Title

United States of America, Wetherhold & Drimer et al. v. Pfizer, Inc.


Case Number

1:06-cv-10204

Court

Massachusetts

Nature of Suit

Other Statutory Actions

Judge

Douglas P. Woodlock

Date Filed

February 2, 2006

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.